Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NovaMedica LLC

www.novamedica.com

Latest From Teijin Pharma Ltd.

Deals Shaping The Medical Industry, June 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in May 2017.

Deals BioPharmaceutical

In Vivo's Deals Of The Month, May 2017

In Vivo's editors pick May's most significant deals, including Thermo Fisher's bid for Patheon and Merck's tie-up with Teijin. (Free article.)

Deals BioPharmaceutical

Pipeline Watch: Phase III Misses For Fovista, Istradefylline And Vonapanitase

Pipeline Watch has been updated to bring greater depth and detail to a potential therapeutic product’s progress through the R&D pipeline. The table brings you a snapshot of selected late-stage clinical trial events in the pharma and biotech industries.

Approvals Pipeline Watch

Positive Asthma Data Prompts Pulmagen To Seek Global Partner For CRTh2 Antagonist

Following positive Phase II data from its CRTh2 antagonist PTR-36 in eosinophilic asthma patients, Pulmagen is looking for a late-stage development partner. PTR-36 is administered at a dose 'an order of magnitude lower' than a competing program from Novartis which is in Phase III, said the small UK firm.

Respiratory Research & Development
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Eastern Europe
        • Russia
  • Parent & Subsidiaries
  • NovaMedica LLC
  • Senior Management
  • Fabrice Egros, Deputy CEO & COO
    Maria Makarova, CFO
    Mikhail Getman, VP, R&D & Regulatory Affairs
    Alojz Pungarsek, VP, Commercial, Sales & Mktg.
    Mary Anderson, VP, Bus. Dev.
  • Contact Info
  • NovaMedica LLC
    Phone: 495 230 02 90
    29, 1-st Brestskaya St.
    Moscow, NJ 117036
    Russia
Advertisement
Advertisement
UsernamePublicRestriction

Register